| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JQ-1:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | apicidin | CTRPv2 | pan-cancer | AAC | 0.094 | 0.002 |
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.085 | 0.002 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | 0.095 | 0.003 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | 0.094 | 0.003 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.003 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | 0.099 | 0.003 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.003 |